These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30218259)

  • 1. Use of Computerized Clinical Decision Support for Diagnostic Stewardship in Clostridioides difficile testing: an Academic Hospital Quasi-Experimental Study.
    Friedland AE; Brown S; Glick DR; Lusby MC; Lemkin D; Leekha S
    J Gen Intern Med; 2019 Jan; 34(1):31-32. PubMed ID: 30218259
    [No Abstract]   [Full Text] [Related]  

  • 2. Test stewardship, frequency and fidelity: Impact on reported hospital-onset Clostridioides difficile.
    Fleming MS; Hess O; Albert HL; Styslinger E; Doll M; Nguyen HJ; McAulay-Kidd S; Hemphill RR; Srivastava T; Cooper KD; Stevens MP; Bearman G
    Infect Control Hosp Epidemiol; 2019 Jun; 40(6):710-712. PubMed ID: 31006411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of a Computerized Clinical Decision Support Tool on Inappropriate Clostridium difficile Testing.
    White DR; Hamilton KW; Pegues DA; Hanish A; Umscheid CA
    Infect Control Hosp Epidemiol; 2017 Oct; 38(10):1204-1208. PubMed ID: 28760168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescriber Behavior in Clostridioides difficile Testing: A 3-Hospital Diagnostic Stewardship Intervention.
    Mizusawa M; Small BA; Hsu YJ; Sharara SL; Advic E; Kauffman C; Milstone AM; Feldman L; Pahwa AK; Trivedi JB; Landrum MB; Maragakis LL; Carroll KC; Cosgrove SE; Rock C
    Clin Infect Dis; 2019 Nov; 69(11):2019-2021. PubMed ID: 31125399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing.
    Quan KA; Yim J; Merrill D; Khusbu U; Madey K; Dickey L; Dangodara AA; Rudkin SE; O'Brien M; Thompson D; Parekh N; Albers CG; Wilson WC; Thrupp L; Bittencourt CE; Huang SS; Gohil SK
    Infect Control Hosp Epidemiol; 2018 May; 39(5):625-627. PubMed ID: 29552992
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive.
    Madden GR; German Mesner I; Cox HL; Mathers AJ; Lyman JA; Sifri CD; Enfield KB
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):737-740. PubMed ID: 29644943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing Clostridium difficile Colitis Rates Via Cost-Saving Diagnostic Stewardship.
    Yen C; Holtom P; Butler-Wu SM; Wald-Dickler N; Shulman I; Spellberg B
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):734-736. PubMed ID: 29611494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Clostridioides difficile Tests Among Solid Organ Transplant Recipients Through a Diagnostic Stewardship Bundled Intervention.
    Madden GR; Sifri CD
    Ann Transplant; 2019 May; 24():304-311. PubMed ID: 31133632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost Analysis of Computerized Clinical Decision Support and Trainee Financial Incentive for Clostridioides difficile Testing.
    Madden GR; Cox HL; Poulter MD; Lyman JA; Enfield KB; Sifri CD
    Infect Control Hosp Epidemiol; 2019 Feb; 40(2):242-244. PubMed ID: 30466495
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimizing testing for Clostridium difficile infection: A quality improvement project.
    Sperling K; Priddy A; Suntharam N; Feuerhake T
    Am J Infect Control; 2019 Mar; 47(3):340-342. PubMed ID: 30420098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of an electronic medical record nudge on reducing testing for hospital-onset
    Howard-Anderson JR; Sexton ME; Robichaux C; Wiley Z; Varkey JB; Suchindran S; Albrecht B; Ashley Jones K; Fridkin SK; Jacob JT
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):411-417. PubMed ID: 32036798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions.
    Kociolek LK; Patel SJ; Zheng X; Todd KM; Shulman ST; Gerding DN
    Pediatr Infect Dis J; 2016 Feb; 35(2):157-61. PubMed ID: 26517329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic testing methods for Clostridium difficile infection: A statewide survey of Ohio acute care hospitals.
    Wong KK; Choi B; Fraser TG; Donskey CJ; Deshpande A
    Am J Infect Control; 2017 Mar; 45(3):306-307. PubMed ID: 28029400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Clinical Decision Support Alerts on Clostridioides difficile Testing: A Systematic Review.
    Dunn AN; Radakovich N; Ancker JS; Donskey CJ; Deshpande A
    Clin Infect Dis; 2021 Mar; 72(6):987-994. PubMed ID: 32060501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Wilcox MH
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1949-1956. PubMed ID: 27590621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.
    Kociolek LK; Kutty PK; Polgreen PM; Beekmann SE
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):276-280. PubMed ID: 30767829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Decision Support Systems to Reduce Unnecessary Clostridioides difficile Testing Across Multiple Hospitals.
    Rock C; Abosi O; Bleasdale S; Colligan E; Diekema DJ; Dullabh P; Gurses AP; Heaney-Huls K; Jacob JT; Kandiah S; Lama S; Leekha S; Mayer J; Mena Lora AJ; Morgan DJ; Osei P; Pau S; Salinas JL; Spivak E; Wenzler E; Cosgrove SE
    Clin Infect Dis; 2022 Sep; 75(7):1187-1193. PubMed ID: 35100620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
    Alnimr A; Alwazzeh MJ; Al-Ameer A
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?
    Theiss AM; Balla A; Ross A; Francis D; Wojewoda C
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743303
    [No Abstract]   [Full Text] [Related]  

  • 20. Utilizing a real-time discussion approach to improve the appropriateness of
    Dbeibo L; Brinkman A; Beeler C; Fadel W; Snyderman W; Hatfield N; Sadowski J; Wang Y; Kelley K; Webb D; Azar J; Kara A
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1215-1218. PubMed ID: 32594961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.